Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Chinese Medical Journal ; (24): 2521-2524, 2008.
Article in English | WPRIM | ID: wpr-265903

ABSTRACT

<p><b>BACKGROUND</b>The diagnostic value of virtual imaging combined with three-dimensional computed tomographic angiography (3D-CTA) for intracranial aneurysms has not been fully elucidated yet. This study aimed to evaluate the value of combined application of virtual imaging techniques and 3D-CTA in diagnosing patients with aneurismal subarachnoid hemorrhage (SAH) at the acute stage.</p><p><b>METHODS</b>Eighty patients with non-traumatic SAH received 3D-CTA examinations. The raw CT data of these patients were reconstructed and transferred into the 3D mode through the surgical plan system based on virtual reality (VR) image, and the 3D virtual images of skulls and brain blood vessels were acquired. The location, size and shape of aneurysms and their anatomic relationship with adjacent tissues were measured from many points of view.</p><p><b>RESULTS</b>Seventy-three aneurysms were detected in 68 of the 80 patients, but 2 aneurysms were detected in 2 of the 5 patients who had been found free of aneurysms previously and had received 3D-CTA examinations for a second time one month later. The 3D virtual images produced by the virtual imaging system were clear and vivid, and they could reveal the location and size of the aneurysm and its relations to the parent artery and skull directly.</p><p><b>CONCLUSIONS</b>The imaging of 3D-CTA is convenient, reliable and fast in diagnosing intracranial aneurysms and can be regarded as the first choice for the diagnosis and treatment of ruptured intracranial aneurysms. Combined with the surgical plan system based on the VR image, 3D-CTA may obtain more imaging information about aneurysms.</p>


Subject(s)
Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Young Adult , Angiography , Methods , Imaging, Three-Dimensional , Methods , Intracranial Aneurysm , Diagnostic Imaging , General Surgery , Tomography, X-Ray Computed , Methods
2.
Journal of Southern Medical University ; (12): 213-215, 2008.
Article in Chinese | WPRIM | ID: wpr-293414

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the value of virtual imaging technique in diagnosis of intracranial aneurysms.</p><p><b>METHODS</b>Fifty-four cases of 54 intracranial aneurysm diagnosed by three-dimensional CT angiography (3D-CTA) examinations were enrolled in this study. Three-dimensional virtual images of the skull and cerebral vessels were acquired by three-dimensional reconstruction of the original CT images using the surgical planning system, and the location, size and shape of the aneurysms and their anatomical relationship with the adjacent tissues were observed and measured from several angles. All the patients underwent surgical planning and simulated surgical operations using the virtual surgical instruments available in the system.</p><p><b>RESULTS</b>All the 54 cases had successful three-dimensional virtual image reconstruction and the surgical planning operations. The virtual imaging system generated clear and vivid three-dimensional virtual images which clearly visualized the location and size of the aneurysms and their precise anatomical relations to the parent arteries and skull. This virtual reality imaging system also allowed simulation of simple surgical procedures.</p><p><b>CONCLUSION</b>The surgical planning system based on the virtual reality imaging can serve as a useful means to assist the diagnosis and provide precise imaging details of intracranial aneurysms.</p>


Subject(s)
Humans , Cerebral Angiography , Methods , Imaging, Three-Dimensional , Methods , Intracranial Aneurysm , Diagnostic Imaging , Tomography, X-Ray Computed , Methods
3.
Journal of Southern Medical University ; (12): 712-714, 2007.
Article in Chinese | WPRIM | ID: wpr-268040

ABSTRACT

<p><b>OBJECTIVE</b>To study the effect of chemotherapy with drugs selected according to drug sensitivity test and drug- resistance gene assessment in mice bearing tumors derived from high-passage gastric cancer cells.</p><p><b>METHODS</b>Chemosensitivity of the mouse gastric cancer cells to 6 chemotherapeutic drugs was investigated using MTT assay before the 6 drugs were applied in mice with implanted tumors. The implanted tumor volume and tumor inhibition rate were observed, and the expression of the multidrug resistance-1 (MDR1) gene was detected.</p><p><b>RESULTS</b>5-FU, the most sensitive among the 6 drugs, resulted in significantly higher tumor inhibition rates in comparison with the control group, but did not significant affect MDR1 expression. Adriamycin (ADM) had the lowest sensitivity with low tumor inhibition rates and no significant effect on MDR1 expression. Cisplatin (DDP) was identified as the most sensitive drug for mouse gastric cancer with previous 5-FU exposure, and Mitomycin (MMC) was the most insensitive drug for mouse gastric cancer with previous ADM treatment. In mice bearing tumors of the second-passage cells, DDP showed high tumor inhibition rate but scarcely affected MDR1 expression; MMC resulted in low tumor inhibition rate and high MDR1 expression. Application of 5-FU and ADM in these tumor-bearing mice of the second-passage cancer cells resulted in rather low tumor inhibition rates without significant alterations in MDR1 expression as compared with the control group.</p><p><b>CONCLUSION</b>Appropriate individualized chemotherapy should be implemented in full consideration of the results of drug sensitivity test and drug-resistance gene assessment.</p>


Subject(s)
Animals , Mice , ATP Binding Cassette Transporter, Subfamily B, Member 1 , Antineoplastic Agents , Pharmacology , Carboplatin , Pharmacology , Cell Line, Tumor , Cisplatin , Pharmacology , Doxorubicin , Pharmacology , Drug Screening Assays, Antitumor , Fluorouracil , Pharmacology , Immunohistochemistry , Mitomycin , Pharmacology , Neoplasm Transplantation , Stomach Neoplasms , Drug Therapy , Metabolism , Pathology , Treatment Outcome , Tumor Burden
SELECTION OF CITATIONS
SEARCH DETAIL